Valeant Pays Down $220 Million in Unscheduled Debt Payments

Valeant Pharmaceutical Industries Inc. said Monday it has made $220 million in unscheduled payments in the drug company’s latest effort to reduce its multibillion-dollar debt.

from WSJ.com: US Business http://ift.tt/2pOG8Fi
via IFTTT